Agitation: Clinical Trials

93 trials for Agitation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 completed, 13 unknown, 8 recruiting, 6 terminated. 28 Not applicable, 23 Phase 4, 17 Phase 3, 15 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable28Completed 16, Unknown 5, Not yet recruiting 3, Recruiting 2, Terminated 2
Phase 423Completed 14, Unknown 4, Withdrawn 4, Not yet recruiting 1
Phase 317Completed 11, Recruiting 3, Terminated 2, Active not recruiting 1
Phase 215Completed 9, Recruiting 2, Terminated 2, Active not recruiting 1, Withdrawn 1
Phase 11Completed 1

Follow Agitation: new trials by email Literature Review of Agitation trials Research Report on Agitation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Virtual Reality to Advance Dementia Care and Quality of Life
Supervised Virtual Reality Sessions - Dementia, Agitation
Not applicableNot yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's102026-12-012026-10-26
Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial
Esketamine combined with dexmedetomidine, Dexmedetomidine - Dexmedetomidine, Ketamine
Phase 4Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University3562026-09-282026-09-03
Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years
Daily Screen Exposure Duration - Agitation, Postoperative Agitation
RecruitingKanuni Sultan Suleyman Training and Research Hospital2882026-05-012026-08-05
PARO-agitation-study
PARO - Agitation, POSTOPERATIVE DELIRIUM AND POSTOPERATIVE COGNITIVE DECLINE
Not applicableRecruitingHannover Medical School3002025-12-152026-05-05
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
KarXT, KarX-EC - Alzheimer Disease, Agitation
Phase 3RecruitingBristol-Myers Squibb6502025-12-022026-10-16
Impact of Harp Therapy on Behavioral Disorders in Nursing Home Residents With Neurodegenerative Disease (ARPE)
Harp therapy (receptive music therapy) - Neurodegenerative Diseases, Behavioral Symptoms
CompletedLNA SANTE252025-10-012026-08-07
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
12 cm2 - 2 Active DMTS Patches, 6 cm2 - 1 Active and 1 Placebo DMTS Patches, Placebo - 2 Placebo DMTS Patches - Agitation
Phase 2Active not recruitingTeikoku Pharma USA, Inc.1502025-09-162026-10-27
Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery
A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium., Routine post-operative management and standard delirium reduction measures. - Delirium - Postoperative, Agitation
Not applicableNot yet recruitingUniversity of British Columbia602025-09-012025-07-03
Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.
Risk Behavior, Agitation
RecruitingUniversity Hospital, Clermont-Ferrand202025-07-092025-07-14
Comparison of Haloperidol and Dexmedetomidine for Delirium and Agitation in ICU Patients With Traumatic Brain Injury
Haloperidol, Dexmedetomidine - Traumatic Brain Injury, Delirium
Not applicableNot yet recruitingBenha University402025-06-152025-05-28
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
BMS-986368, Placebo - Agitation, Alzheimer Disease
Phase 2RecruitingCelgene1202025-06-092026-10-06
Acute Agitation in Emergency Psychiatry
Sublingual Dexmedetomidine, Buccal midazolam, Oral lorazepam - Agitation
Phase 2 / Phase 3RecruitingLone Baandrup1322024-12-302025-01-01
Family Videos and Virtual Reality in Intensive Care Patients
Family Video.Participants watched a five-minute video prepared by their family members twice daily on the second and third days of intensive care. - Anxiety, Agitation
Not applicableCompletedSennur Kula Şahin722024-10-202026-09-01
Neurosteer Bedside Monitoring System
Neurosteer's single-channel EEG monitoring device - Delirium, Sedation
Not applicableRecruitingIcahn School of Medicine at Mount Sinai1002024-07-082026-09-28
Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
T2:C100, Placebo - Agitation, Dementia
Phase 2CompletedUniversity of Southern California1202024-01-052026-09-02
Doll Therapy for Agitated Elderly Dementia People
doll therapy - Dementia, Agitation
Not applicableCompletedKaradeniz Technical University602023-12-012025-07-10
Acupressure for Agitation, Pain, and Sleep in Mechanically Ventilated ICU Patients
Acupressure, Light Touch - Mechanical Ventilation, Critical Illness
Not applicableCompletedYang Yun Shiuan602023-10-062026-06-04
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
Sublingual film containing dexmedetomidine (BXCL501) - Agitation, Schizophrenia
Phase 4WithdrawnBrigham and Women's Hospital2023-09-012026-01-28
A Music-Based Mobile App for People Living With Alzheimer's Disease and Related Dementias (ADRD)
Feasibility study of music-based mobile app - Dementia, Agitation
UnknownAutotune Me LLC202023-08-012023-11-24
Premature Enhanced Automated Capture of Comfort Knowledge
Acute Pain, Pain, Procedural
UnknownNewcastle University1002023-02-012023-09-14

Showing 20 of 93. Sign in to see all of them.

Narrower conditions

Psychomotor Agitation (93)  ·  Dementia (18)  ·  Alzheimer Disease (16)  ·  Delirium (15)  ·  Psychotic Disorders (10)  ·  Pain (8)  ·  Aggression (7)  ·  Anxiety Disorders (7)  ·  Schizophrenia (7)  ·  Emergence Delirium (6)  ·  Behavior (3)  ·  Depression (3)  ·  Acute Pain (2)  ·  Agnosia (2)  ·  Behavioral Symptoms (2)

Broader conditions

Dyskinesias (93)  ·  Nervous System Diseases (93)  ·  Neurobehavioral Manifestations (93)  ·  Neurologic Manifestations (93)  ·  Pathological Conditions, Signs and Symptoms (93)  ·  Psychomotor Disorders (93)  ·  Signs and Symptoms (93)  ·  Aberrant Motor Behavior in Dementia (92)  ·  Behavioral Symptoms (91)  ·  Behavior (90)  ·  Mental Disorders (60)  ·  Neurocognitive Disorders (49)  ·  Brain Diseases (30)  ·  Central Nervous System Diseases (30)  ·  Confusion (20)

Interventions

Dexmedetomidine (21)  ·  Haloperidol (9)  ·  Saline Solution (6)  ·  Sodium Chloride (6)  ·  Risperidone (4)  ·  Lorazepam (3)  ·  Midazolam (3)  ·  Standard of Care (3)  ·  Acupuncture Therapy (2)  ·  Fentanyl (2)  ·  Olanzapine (2)  ·  Quetiapine Fumarate (2)  ·  Remifentanil (2)  ·  nabilone (2)  ·  1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate (1)

Sponsors

BioXcel Therapeutics Inc (6)  ·  Hennepin Healthcare Research Institute (3)  ·  New York State Psychiatric Institute (3)  ·  Ain Shams University (2)  ·  Alexandria University (2)  ·  Brigham and Women's Hospital (2)  ·  China Medical University Hospital (2)  ·  Prince of Songkla University (2)  ·  Seoul National University Hospital (2)  ·  Sunnybrook Health Sciences Centre (2)  ·  University Hospital, Clermont-Ferrand (2)  ·  University of Southern California (2)  ·  Abarbanel Mental Health Center (1)  ·  Ajou University School of Medicine (1)  ·  Assiut University (1)

Countries

United States (38)  ·  China (10)  ·  Canada (8)  ·  Egypt (5)  ·  Turkey (Türkiye) (5)  ·  France (4)  ·  Norway (4)  ·  South Korea (4)  ·  Taiwan (4)  ·  Spain (3)  ·  United Kingdom (3)  ·  Argentina (2)  ·  Croatia (2)  ·  Germany (2)  ·  Israel (2)

Top investigators

BioXcel MM, MD (5)  ·  Jacobo Mintzer, MD (2)  ·  Ahmad Ben Tareef, MD (1)  ·  Alaa Elkateb, MD (1)  ·  Alana Flexman, MD MBA (1)  ·  Anne Lynn, MD (1)  ·  Anton Porsteinsson, MD (1)  ·  Bettina S. Husebo, MD, PhD (1)  ·  Brent P Forester, MD (1)  ·  Brigid Reynolds, NP (1)  ·  Bruce Pollock, MD (1)  ·  Claudia Cooper (1)

Results publications

PMID 10692189, PMID 19454032, PMID 21765198, PMID 21845596, PMID 22143072, PMID 23075176, PMID 23524149, PMID 23611363, PMID 24549548, PMID 24566243, PMID 24606117, PMID 24806873, PMID 24914549, PMID 25493435, PMID 25791540, PMID 26880794, PMID 27247487, PMID 27524403, PMID 27855483, PMID 28936121, PMID 29136228, PMID 29249041, PMID 29859917, PMID 29866205, PMID 30031556, PMID 30032888, PMID 30282677, PMID 30548977, PMID 30753761, PMID 31003871, PMID 31182351, PMID 31322567, PMID 31547752, PMID 31672419, PMID 32528650, PMID 34059401, PMID 34532852, PMID 35703367, PMID 36002761, PMID 36198061, PMID 36506775, PMID 36733413, PMID 37732619, PMID 40466557, PMID 40562636, PMID 41160116

NIH funding

2008 (1), 2017 (1), 2023 (1), P30AG073105 (1), R01AG021488 (1), R01AG031348 (1), R01AG047146 (1), R01AG068324 (1), R01AG095004 (1), R01MH055735 (1)